265
Views
18
CrossRef citations to date
0
Altmetric
Articles

Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine

, , , , &
Pages 1207-1218 | Received 11 Aug 2012, Accepted 29 Aug 2012, Published online: 17 Oct 2012

References

  • Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G., & de Cabo, R. (2012). Are sirtuins viable targets for improving healthspan and lifespan? Nature Reviews Drug Discovery, 11, 443–461.
  • Blander, G., & Guarente, L. (2004). The Sir2 family of protein deacetylases. Annual Review of Biochemistry, 73, 417–435.
  • Borradaile, N. M., & Pickering, J. G. (2009). NAD(+), sirtuins, and cardiovascular disease. Current Pharmaceutical Design, 15, 110–117.
  • Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy minimization and dynamics calculations. Journal of Computational Chemistry, 4, 187–217.
  • Chang, T. T., Chen, K. C., Chang, K. W., Chen, H. Y., Tsai, F. J., Sun, M. F., & Chen, C. Y. C. (2011). In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular Biosystems, 7, 2702–2710.
  • Chang, S. S., Huang, H. J., & Chen, C. Y. C. (2011a). Two birds with one stone? Possible dual-targeting H1N1 inhibitors from Traditional Chinese Medicine. PLoS Computational Biology, 7, e1002315.
  • Chang, S. S., Huang, H. J., & Chen, C. Y. C. (2011b). High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan. Molecular Biosystems, 7, 3366–3374.
  • Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Fisher, M., Lin, J. G., & Chen, C. Y. C. (2011). Screening from the world’s largest TCM database against H1N1 virus. Journal of Biomolecular Structure & Dynamics, 28, 773–786.
  • Chang, K. W., Tsai, T. Y., Chen, K. C., Yang, S. C., Huang, H. J., Chang, T. T., & Chen, C. Y. C. (2011). iSMART: An integrated cloud computing web server for Traditional Chinese Medicine for online virtual screening, de novo evolution and drug design. Journal of Biomolecular Structure & Dynamics, 29, 243–250.
  • Chang, P. C., Wang, J. D., Lee, M. M., Chang, S. S., Tsai, T. Y., Chang, K. W., & Chen, C. Y. C. (2011). Lose weight with Traditional Chinese Medicine? Potential suppression of fat mass and obesity-associated protein. Journal of Biomolecular Structure & Dynamics, 29, 471–483.
  • Chen, Y. C. (2007). The molecular dynamic simulation of zolpidem interaction with gamma aminobutyric acid type A receptor. Journal of the Chinese Chemical Society, 54, 653–658.
  • Chen, C. Y. C. (2010). Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors. Journal of the Taiwan Institute of Chemical Engineers, 41, 143–149.
  • Chen, C. Y. C. (2011). TCM database@Taiwan: The world’s largest Traditional Chinese Medicine database for drug screening in silico. PLoS ONE, 6, e15939.
  • Chen, C. Y. C. (2012). Mechanism of BAG1 repair on Parkinson’s disease-linked DJ1 mutation. Journal of Biomolecular Structure and Dynamics, 30, 1–12.
  • Chen, K. Y., Chang, S. S., & Chen, C. Y. C. (2012). In silico identification of potent pancreatic triacylglycerol lipase inhibitors from Traditional Chinese Medicine. PLoS One, 7, e43932.
  • Chen, K. C., Chang, K. W., Chen, H. Y., & Chen, C. Y. C. (2011). Traditional Chinese Medicine, a solution for reducing dual stroke risk factors at once? Molecular Biosystems, 7, 2711–2719.
  • Chen, K. C., Chang, S. S., Huang, H. J., Lin, T. L., Wu, Y. J., & Chen, C. Y. C. (2012). Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from Traditional Chinese Medicine. Journal of Biomolecular Structure and Dynamics, 30, 662–683.
  • Chen, K. C., & Chen, C. Y. C. (2011). Stroke prevention by Traditional Chinese Medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter, 7, 4001–4008.
  • Chen, C. Y. C., Chen, G. W., & Chen, W. Y. C. (2008). Molecular simulation of HER2/neu degradation by inhibiting HSP90. Journal of the Chinese Chemical Society, 55, 297–302.
  • Chen, C. Y., Huang, H. J., Tsai, F. J., & Chen, C. Y. C. (2010). Drug design for influenza A virus subtype H1N1. Journal of the Taiwan Institute of Chemical Engineers, 41, 8–15.
  • Chen, K. C., Sun, M. F., Yang, S. C., Chang, S. S., Chen, H. Y., Tsai, F. J., & Chen, C. Y. C. (2011b). Investigation into potent inflammation inhibitors from Traditional Chinese Medicine. Chemical Biology & Drug Design, 78, 679–688.
  • Colak, Y., Ozturk, O., Senates, E., Tuncer, I., Yorulmaz, E., Adali, G., & Enc, F. Y. (2011). SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 17, 5–9.
  • Denu, J. M. (2005). The Sir 2 family of protein deacetylases. Current Opinion in Chemical Biology, 9, 431–440.
  • Fletcher, R. (1969). Optimization. New York, NY: Academic Press.
  • Fletcher, R., & Reeves, C. M. (1964). Function minimization by conjugate gradients. Computer Journal, 7, 149–154.
  • Guarani, V., Deflorian, G., Franco, C. A., Kruger, M., Phng, L. K., Bentley, K., & Potente, M. (2011). Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature, 473, 234–238.
  • Haigis, M. C., & Sinclair, D. A. (2010). Mammalian sirtuins: Biological insights and disease relevance. Annual Review of Pathology, 5, 253–295.
  • Hsu, C. P., Odewale, I., Alcendor, R. R., & Sadoshima, J. (2008). Sirt1 protects the heart from aging and stress. Biological Chemistry, 389, 221–231.
  • Huang, H. J., Yu, H. W., Chen, C. Y., Hsu, C. H., Chen, H. Y., Lee, K. J., & Chen, C. Y. C. (2010). Current developments of computer-aided drug design. Journal of the Taiwan Institute of Chemical Engineers, 41, 623–635.
  • Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., & Tsai, L. H. (2007). SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. The EMBO Journal, 26, 3169–3179.
  • Lappalainen, Z. (2011). Sirtuins: A family of proteins with implications for human performance and exercise physiology. Research in Sports Medicine, 19, 53–65.
  • Lin, C. H., Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Chang, K. L., & Chen, C. Y. C. (2011). Potent inhibitor design against H1N1 swine influenza: Structure-based and molecular dynamics analysis for M2 inhibitors from Traditional Chinese Medicine database. Journal of Biomolecular Structure & Dynamics, 28, 471–482.
  • Lin, T. L., & Song, G. (2011). Efficient mapping of ligand migration channel networks in dynamic proteins. Proteins: Structure Function and Genetics, 79, 2475–2490.
  • Lovell, S. C., Davis, I. W., Arendall, W. B., 3rd, de Bakker, P. I., Word, J. M., Prisant, M. G., & Richardson, D. C. (2003). Structure validation by Calpha geometry: Phi, psi and Cbeta deviation. Proteins: Structure Function and Genetics, 50, 437–450.
  • Medda, F., Russell, R. J. M., Higgins, M., McCarthy, A. R., Campbell, J., Slawin, A. M. Z., & Westwood, N. J. (2009). Novel cambinol analogs as sirtuin inhibitors: Synthesis, biological evaluation, and rationalization of activity. Journal of Medicinal Chemistry, 52, 2673–2682.
  • Pulla, V. K., Battu, M. B., Alvala, M., Sriram, D., & Yogeeswari, P. (2012). Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review. Expert opinion on therapeutic targets, 16, 819–832.
  • Ramalho, T. C., Franca, T. C. C., Cortopassi, W. A., Goncalves, A. S., da Silva, A. W. S., & da Cunha, E. F. F. (2011). Topology and dynamics of the interaction between 5-nitroimidazole radiosensitizers and duplex DNA studied by a combination of docking, molecular dynamic simulations and NMR spectroscopy. Journal of Molecular Structure, 992, 65–71.
  • Roy, A., Kucukural, A., & Zhang, Y. (2010). I-TASSER: A unified platform for automated protein structure and function prediction. Nature Protocols, 5, 725–738.
  • Sakkiah, S., Thangapandian, S., Park, C., Son, M., & Lee, K. W. (2012). Molecular docking and dynamics simulation, receptor-based hypothesis: Application to identify novel sirtuin 2 inhibitors. Chemical Biology & Drug Design, 80, 315–327.
  • Stein, S., & Matter, C. M. (2011). Protective roles of SIRT1 in atherosclerosis. Cell Cycle, 10, 640–647.
  • Sun, M. F., Chang, T. T., Chang, K. W., Huang, H. J., Chen, H. Y., Tsai, F. J., & Chen, C. Y. (2011). Blocking the DNA repair system by Traditional Chinese Medicine? Journal of Biomolecular Structure & Dynamics, 28, 895–906.
  • Sun, M. F., Chen, H. Y., Tsai, F. J., Liu, S. H., Chen, C. Y., & Chen, C. Y. C. (2011). Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: Identifying DNA repair protein XRCC4 inhibitors. Journal of Biomolecular Structure & Dynamics, 29, 325–337.
  • Tang, B. L. (2009). Sirt1’s complex roles in neuroprotection. Cellular and Molecular Neurobiology, 29, 1093–1103.
  • Tang, B. L. (2011). Sirt1’s systemic protective roles and its promise as a target in antiaging medicine. Translational Research: The Journal of Laboratory and Clinical Medicine, 157, 276–284.
  • Tanner, K. G., Landry, J., Sternglanz, R., & Denu, J. M. (2000). Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proceedings of the National Academy of Sciences of the United States of America, 97, 14178–14182.
  • Tou, W. I., & Chen, C. Y. C. (2012a). Traditional Chinese Medicine as dual guardians against hypertension and cancer? Journal of Biomolecular Structure and Dynamics, 30, 299–317.
  • Tou, W. I., & Chen, C. Y. C. (2012b). In silico investigation of potential Src kinase ligands from Traditional Chinese Medicine. PLoS One, 7, e33728.
  • Tsai, T. Y., Chang, K. W., & Chen, C. Y. C. (2011). IScreen: World’s first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. Journal of Computer-Aided Molecular Design, 25, 525–531.
  • Tsai, K. N., Chen, G. W., & Chen, C. Y. C. (2012). A novel algorithm for identification of activated cryptic 5′ splice sites. Journal of Biomolecular Structure and Dynamics, 29, 1089–1099.
  • Venkatachalam, C. M., Jiang, X., Oldfield, T., & Waldman, M. (2003). LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling, 21, 289–307.
  • Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein–ligand interactions. Protein Engineering, 8, 127–134.
  • Yang, S. C., Chang, S. S., & Chen, C. Y. C. (2011). Identifying HER2 inhibitors from natural products database. PLoS One, 6, e28793.
  • Yang, S. C., Chang, S. S., Chen, H. Y., & Chen, C. Y. C. (2011). Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology, 7, e1002189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.